Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets

Published:2018-01-17 Issue: Volume:8 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Cuesta-Mateos Carlos,Alcaraz-Serna Ana,Somovilla-Crespo Beatriz,Muñoz-Calleja Cecilia

Funder

Instituto de Salud Carlos III

Ministerio de Economía y Competitividad

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference396 articles.

1. Mechanistic considerations for the use of monoclonal antibodies for cancer therapy;Glassman;Cancer Biol Med,2014

2. Antibody therapy of cancer;Scott;Nat Rev Cancer,2012

3. Strategies and advancement in antibody-drug conjugate optimization for targeted cancer therapeutics;Kim;Biomol Ther (Seoul),2015

4. Glycosylation as a strategy to improve antibody-based therapeutics;Jefferis;Nat Rev Drug Discov,2009

5. Engineered antibodies of IgG1/IgG3 mixed isotype with enhanced cytotoxic activities;Natsume;Cancer Res,2008

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD38/NAD+ glycohydrolase and associated antigens in chronic lymphocytic leukaemia: From interconnected signalling pathways to therapeutic strategies;Biochimie;2024-07

2. The Multifaceted Role of Monoclonal Antibodies in Oral Cancer Therapy – A Narrative Overview;Journal of Datta Meghe Institute of Medical Sciences University;2024-04

3. Prospective effect of linkers type on the anticancer activity of pemetrexed-monoclonal antibody (atezolizumab) conjugates;F1000Research;2024-03-11

4. Cardiovascular Toxicity of Antineoplastic Treatments in Hematological Diseases: Focus on Molecular Mechanisms to Improve Therapeutic Management;Journal of Clinical Medicine;2024-03-09

5. Nanotechnology in leukemia: diagnosis, efficient-targeted drug delivery, and clinical trials;European Journal of Medical Research;2023-12-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3